Fate Therapeutics
FATE
#9044
Rank
NZ$0.21 B
Marketcap
NZ$1.87
Share price
-1.82%
Change (1 day)
-53.80%
Change (1 year)

Fate Therapeutics (FATE) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$0.40 Billion

According to Fate Therapeutics 's latest financial reports the company has NZ$0.40 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Fate Therapeutics - Net assets on balance sheet (from 2012 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$0.56 B-2.99%
2023-12-31$NZ$0.58 B-23.57%
2022-12-31$NZ$0.76 B-23.31%
2021-12-31$NZ$0.99 B86.53%
2020-12-31$NZ$0.53 B46.61%
2019-12-31$NZ$0.36 B51.91%
2018-12-31$NZ$0.23 B120.11%
2017-12-31$NZ$0.10 B2.91%
2016-12-31$NZ$0.10 B90.02%
2015-12-31$NZ$55.57 M53.65%
2014-12-31$NZ$36.17 M-41.54%
2013-12-31$NZ$61.87 M-196.36%
2012-12-31$-NZ$64.22 Million-1.12%
2011-12-31$-NZ$64.95 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Sarepta Therapeutics
SRPT
NZ$2.28 B 463.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$44.09 B 10,782.83%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-NZ$0.27 Billion-166.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
NZ$3.26 B 705.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$5.19 B 1,183.23%๐Ÿ‡บ๐Ÿ‡ธ USA